Abstract
Tumor cell lines are widely used both as disease models and, increasingly, as genomic resources for the ascertainment of new cancer genes. Cytogenetic analysis remains a major route to uncovering the cancer genome. However, cancer cell lines vary inexplicably in their harvesting preferences, which must, therefore, be determined by trial and error. This article describes harvesting protocols optimized empirically for 550 commonly used, mainly human, cancer cell lines together with evidence-based procedures to assist in determining conditions for unlisted cell lines and subsidiary protocols for cytogenetic analysis using G-banding and fluorescence in situ hybridization.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
Drexler, H.G. The Leukemia–Lymphoma Cell Line Facts Book (Academic Press, London, 2001).
Drexler, H.G. Guide to Leukemia-Lymphoma Cell Lines (DSMZ Braunschweig, Germany, 2005).
MacLeod, R.A. et al. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int. J. Cancer 83, 555–563 (1999).
Mrózek, K., Heinonen, K. & Bloomfield, C.D. Clinical importance of cytogenetics in acute myeloid leukaemia. Baillieres Best Pract. Res. Clin. Haematol. 14, 19–47 (2001).
Swansbury, J. Acute lymphoblastic leukemia: background. Methods Mol. Biol. 220, 59–71 (2003).
Muyrers-Chen, I. et al. Expression of leukemic MLL fusion proteins in Drosophila affects cell cycle control and chromosome morphology. Oncogene 23, 8639–8648 (2004).
Caspersson, T., Zech, L. & Johansson, C. Differential binding of alkylating fluorochromes in human chromosomes. Exp. Cell Res. 60, 315–319 (1970).
Seabright, M. Improvement of trypsin method for banding chromosomes. Lancet 1, 1249–1250 (1973).
Rowley, J.D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290–293 (1973).
Cremer, T., Lichter, P., Borden, J., Ward, D.C. & Manuelidis, L. Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum. Genet. 80, 235–246 (1988).
Lichter, P., Cremer, T., Borden, J., Manuelidis, L. & Ward, D.C. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80, 224–234 (1988).
Lichter, P. Multicolor FISHing: what's the catch? Trends Genet. 12, 475–479 (1997).
ISCN. An international system for human cytogenetic nomenclature: report of the Standing Committee on Human Cytogenetic Nomenclature. Birth Defects Orig. Artic. Ser. 21, 1–117 (1985).
Drexler, H.G., Dirks, W.G., Matsuo, Y. & MacLeod, R.A. False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17, 416–426 (2003).
Tosi, S. et al. Characterization of the human myeloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes, and comparative genomic hybridization. Genes Chromosomes Cancer 24, 213–221 (1999).
MacLeod, R.A. et al. Karyotypic dissection of Hodgkin's disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia 14, 1803–1814 (2000).
Poulsen, T.S. et al. Detection of illegitimate rearrangement within the immunoglobulin locus on 14q32.3 in B-cell malignancies using end-sequenced probes. Genes Chromosomes Cancer 32, 265–274 (2001).
Uphoff, C.C. & Drexler, H.G. Eradication of mycoplasma contaminations. Methods Mol. Biol. 290, 25–34 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Optimal hypotonic treatments for individual cell lines (PDF 423 kb)
Supplementary Table 2
Evidence based assessment of harvesting (PDF 62 kb)
Rights and permissions
About this article
Cite this article
MacLeod, R., Kaufmann, M. & Drexler, H. Cytogenetic harvesting of commonly used tumor cell lines. Nat Protoc 2, 372–382 (2007). https://doi.org/10.1038/nprot.2007.29
Published:
Issue date:
DOI: https://doi.org/10.1038/nprot.2007.29
This article is cited by
-
Nanoscale characterization of drug-induced microtubule filament dysfunction using super-resolution microscopy
BMC Biology (2021)
-
A new ETV6-NTRK3 cell line model reveals MALAT1 as a novel therapeutic target - a short report
Cellular Oncology (2018)
-
Cell lines authentication and mycoplasma detection as minimun quality control of cell lines in biobanking
Cell and Tissue Banking (2017)
-
Mechanisms underlying epigenetic and transcriptional heterogeneity in Chinese hamster ovary (CHO) cell lines
BMC Biotechnology (2016)
-
Scalable expansion of human pluripotent stem cells in suspension culture
Nature Protocols (2011)


